NCT06298474 · RECRUITING

The BRAIN App (Phase 2 SBIR)

This trial is testing a tablet-based app called BRAIN that uses AI to deliver personalized Cognitive Stimulation Therapy to people living with dementia in long-term care. The app pulls from each person's interests and memories to suggest engaging activities, with the goal of improving quality of life and reducing difficult behaviors. This is a Phase NA behavioral study — it is testing real-world effectiveness of a digital tool, not a drug or vaccine.

You may qualify if

  • 65+ years old
  • Clinical diagnosis of dementia (any type)
  • Able to speak conversational English

You're excluded if

  • Completely unable to communicate verbally
  • Serious visual or hearing impairments
  • Signs of rapid decline over the last three months (based upon staff report)

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-06-19

View full record on ClinicalTrials.gov

All APOE4 clinical trials